DIMENSIONAL FUND ADVISORS LP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$41,572,749
-32.9%
2,591,588
-3.1%
0.01%
-30.0%
Q2 2023$61,970,696
-2.1%
2,673,471
-1.9%
0.02%
-4.8%
Q1 2023$63,285,535
+165495.2%
2,724,396
+3.4%
0.02%
+90.9%
Q4 2022$38,217
-99.9%
2,633,864
+8.3%
0.01%
-38.9%
Q3 2022$46,412,000
+0.5%
2,432,450
-4.3%
0.02%
+5.9%
Q2 2022$46,174,000
-28.5%
2,541,207
-0.8%
0.02%
-15.0%
Q1 2022$64,537,000
-11.3%
2,560,944
-2.8%
0.02%
-9.1%
Q4 2021$72,748,000
-16.1%
2,635,803
-1.9%
0.02%
-21.4%
Q3 2021$86,744,000
+2.5%
2,686,376
-3.0%
0.03%
+3.7%
Q2 2021$84,666,000
+2.1%
2,768,704
+1.4%
0.03%0.0%
Q1 2021$82,931,000
+51.8%
2,730,879
-1.1%
0.03%
+35.0%
Q4 2020$54,619,000
+51.2%
2,762,037
-0.3%
0.02%
+33.3%
Q3 2020$36,118,000
+12.2%
2,769,947
-2.4%
0.02%
+7.1%
Q2 2020$32,183,000
-24.7%
2,838,177
-4.9%
0.01%
-36.4%
Q1 2020$42,726,000
-47.2%
2,985,740
+0.5%
0.02%
-24.1%
Q4 2019$80,894,000
-4.3%
2,970,889
+0.7%
0.03%
-12.1%
Q3 2019$84,498,000
+11.6%
2,951,393
+8.3%
0.03%
+13.8%
Q2 2019$75,727,000
-13.0%
2,726,076
+4.0%
0.03%
-17.1%
Q1 2019$87,020,000
+18.2%
2,620,904
+3.5%
0.04%
+6.1%
Q4 2018$73,645,000
-39.4%
2,533,403
-4.1%
0.03%
-28.3%
Q3 2018$121,546,000
+6.5%
2,642,281
-13.5%
0.05%0.0%
Q2 2018$114,175,000
+9.9%
3,055,263
-13.1%
0.05%
+7.0%
Q1 2018$103,908,000
-14.3%
3,516,340
-0.4%
0.04%
-14.0%
Q4 2017$121,303,000
-6.3%
3,531,884
-1.3%
0.05%
-12.3%
Q3 2017$129,527,000
+46.1%
3,580,081
+4.4%
0.06%
+39.0%
Q2 2017$88,636,000
+74.7%
3,430,216
+29.8%
0.04%
+70.8%
Q1 2017$50,742,000
+83.9%
2,642,820
+59.7%
0.02%
+71.4%
Q4 2016$27,587,000
-7.6%
1,654,854
+14.1%
0.01%
-12.5%
Q3 2016$29,858,000
-32.6%
1,450,805
+0.2%
0.02%
-38.5%
Q2 2016$44,324,000
-16.9%
1,448,505
+1.7%
0.03%
-18.8%
Q1 2016$53,314,000
-7.9%
1,424,368
+6.2%
0.03%
-11.1%
Q4 2015$57,881,000
+27.0%
1,341,041
+10.3%
0.04%
+20.0%
Q3 2015$45,569,000
+18.1%
1,215,845
+7.1%
0.03%
+25.0%
Q2 2015$38,584,000
-4.1%
1,135,183
-0.1%
0.02%
-4.0%
Q1 2015$40,236,000
+4.1%
1,136,633
+0.2%
0.02%0.0%
Q4 2014$38,648,000
-10.2%
1,134,659
+1.7%
0.02%
-19.4%
Q3 2014$43,050,000
-0.2%
1,116,137
+0.7%
0.03%
+3.3%
Q2 2014$43,157,000
+15.9%
1,108,845
+1.8%
0.03%
+7.1%
Q1 2014$37,230,000
+60.0%
1,088,948
-1.8%
0.03%
+55.6%
Q4 2013$23,272,000
-11.6%
1,109,258
-1.0%
0.02%
-21.7%
Q3 2013$26,323,000
+11.9%
1,119,930
+27.9%
0.02%
+4.5%
Q2 2013$23,528,000875,6240.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders